WhatistheSymbol
Guerbet trades in the stock market under the ticker symbol of GBT. Search for the ticker of any public company above using the 'Get Ticker' search in red.

Who is Guerbet?


Warning: fopen(/home/whatist/public_html/symbol/cache/scraperDScache_getCompanyDetails_GBT) [function.fopen]: failed to open stream: Permission denied in /home/whatist/public_html/symbol/classes/class.cache.php on line 66
1,455 Employees
Last Reported Date: 04/11/14
Founded in 1901
Last €30.35 EUR
Change Today +0.50 / 1.68%
Volume 13.6K
As of 11:35 AM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

guerbet (GBT) Snapshot

Open
€30.00
Previous Close
€29.85
Day High
€30.49
Day Low
€29.90
52 Week High
04/14/14 - €35.00
52 Week Low
08/2/13 - €20.40
Market Cap
370.3M
Average Volume 10 Days
12.1K
EPS TTM
€1.68
Shares Outstanding
12.2M
EX-Date
06/2/14
P/E TM
18.1x
Dividend
€0.50
Dividend Yield
1.65%
Request Investor Kit
GBT:FP Advanced Stock Chart

Related News

No related news articles were found.

guerbet (GBT) Related News

No Related News Found

guerbet (GBT) Key Developments

Guerbet SA Announces Consolidated Sales Results for the First Quarter Ended March 2014

Guerbet SA announced consolidated sales results for the first quarter ended March 2014. For the period, the company reported sales of EUR 96.6 million, up 6.1% (+8.4% excluding currency effects) from the same period last year.

GUERBET Diary to Report Q1, 2014 Sales/Trading Statement Results on Apr 29, 2014

GUERBET Diary announced that they will report Q1, 2014 sales/trading statement results on Apr 29, 2014

Guerbet Announces United States Food and Drug Administration Approves Lipiodol

Guerbet announced that Lipiodol was approved by the United States Food and Drug Administration pursuant to section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act indicated for selective hepatic intra-arterial use for imaging tumors in adults with known hepatocellular carcinoma. This approval was received shortly after FDA granted approval to a new site to manufacture Lipiodol, validated for United States distribution only. The company plans to transition from the temporary importation program as soon as product from the newly approved manufacturing plant will be available in the United States. Lipiodol is contraindicated in patients with hypersensitivity to Lipiodol, hyperthyroidism, traumatic injuries, recent hemorrhage or bleeding. Lipiodol is indicated for hysterosalpingography in adults, lymphography in adults and children, and selective hepatic intra-arterial use for imaging tumors in adults with known HCC.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GBT:FP €30.35 EUR +0.50

GBT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bayer AG €100.29 EUR +0.54
Covidien PLC $89.29 USD +0.40
Mallinckrodt PLC $75.65 USD +1.30
 

Industry Analysis

GBT

Industry Average

Valuation GBT Industry Range
Price/Earnings 18.2x
Price/Sales 0.9x
Price/Book 1.5x
Price/Cash Flow 8.4x
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

No related news found for this Guerbet.
  • 0
  • 0
  • 0

Get our Stock Market & Financial Investment news alerts in your inbox

Read our full disclaimer and privacy policy